AbClon Company Description

AbClon Inc. engages in the research and development of antibody drugs in South Korea and Sweden.

The company’s products in pipeline include NEST platform technology products for breast and gastric cancers; AffiMab platform technology products for colon cancer and autoimmune diseases; and CAR-T platform technology products for hematologic and ovarian cancers.

AbClon Inc. was founded in 2010 and is based in Seoul, South Korea.

AbClon Inc.

Country	South Korea
Founded	2010
Industry	Biological Products, Except Diagnostic Substances

Contact Details

Address: 1401 285, Digital-ro Seoul, 08381 South Korea
Phone	82 2 2109 1294
Website	abclon.com

Stock Details

Ticker Symbol	174900
Exchange	KOSDAQ
Fiscal Year	January - December
Reporting Currency	KRW
SIC Code	2836